112 related articles for article (PubMed ID: 10419920)
21. Electrophysiologic studies on the spinal antinociceptive action of kappa opioid agonists in the adult and 21-day-old rat.
Sullivan AF; Dickenson AH
J Pharmacol Exp Ther; 1991 Mar; 256(3):1119-25. PubMed ID: 2005577
[TBL] [Abstract][Full Text] [Related]
22. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
23. Effects of intravenous mu and kappa opioid receptor agonists on sensory responses of convergent neurones in the dorsal horn of spinalized rats.
Dong XW; Parsons CG; Headley PM
Br J Pharmacol; 1991 May; 103(1):1230-6. PubMed ID: 1652344
[TBL] [Abstract][Full Text] [Related]
24. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Zhang J; Haddad GG; Xia Y
Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
[TBL] [Abstract][Full Text] [Related]
25. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
Riviere PJ; Pascaud X; Chevalier E; Junien JL
J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
[TBL] [Abstract][Full Text] [Related]
26. Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist.
Rong F; Peng Z; Ye MX; Zhang QY; Zhao Y; Zhang SM; Guo HT; Hui B; Wang YM; Liang C; Gu CH; Tao C; Cui Q; Yu SQ; Yi DH; Pei JM
Arch Med Res; 2009 May; 40(4):227-34. PubMed ID: 19608010
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
28. Quaternary ammonium salt of U50488H, a new κ-opioid receptor agonist, protects rat heart against ischemia/reperfusion injury.
Wang Q; Sun Y; Li J; Xing W; Zhang S; Gu X; Feng N; Zhao L; Fan R; Wang Y; Yin W; Pei J
Eur J Pharmacol; 2014 Aug; 737():177-84. PubMed ID: 24855042
[TBL] [Abstract][Full Text] [Related]
29. Effect of fedotozine on human distal colon.
Adami M; Bertaccini G; Roncoroni L; Cobianchi F
Ital J Gastroenterol; 1996; 28(8):441-6. PubMed ID: 9032586
[TBL] [Abstract][Full Text] [Related]
30. Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat.
Gu B; Fraser MO; Thor KB; Dolber PC
J Urol; 2004 Jan; 171(1):472-7. PubMed ID: 14665958
[TBL] [Abstract][Full Text] [Related]
31. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
Delvaux M; Louvel D; Lagier E; Scherrer B; Abitbol JL; Frexinos J
Gastroenterology; 1999 Jan; 116(1):38-45. PubMed ID: 9869600
[TBL] [Abstract][Full Text] [Related]
32. Sodium channel blocking actions of the kappa-opioid receptor agonist U50,488 contribute to its visceral antinociceptive effects.
Su X; Joshi SK; Kardos S; Gebhart GF
J Neurophysiol; 2002 Mar; 87(3):1271-9. PubMed ID: 11877501
[TBL] [Abstract][Full Text] [Related]
33. Neurophysiological evidence for increased kappa opioidergic control of spinal cord neurons in rats with unilateral inflammation at the ankle.
Stiller RU; Grubb BD; Schaible HG
Eur J Neurosci; 1993 Nov; 5(11):1520-7. PubMed ID: 8287195
[TBL] [Abstract][Full Text] [Related]
34. Stimulus intensity and the comparative efficacy of mu- and kappa-opioid agonists on nociceptive spinal reflexes in the rat.
Thorn SA; Herrero JF; Headley PM
Brain Res; 1994 Nov; 663(2):352-6. PubMed ID: 7874523
[TBL] [Abstract][Full Text] [Related]
35. Spinal NMDA receptors contribute to neuronal processing of acute noxious and nonnoxious colorectal stimulation in the rat.
Ji Y; Traub RJ
J Neurophysiol; 2001 Oct; 86(4):1783-91. PubMed ID: 11600639
[TBL] [Abstract][Full Text] [Related]
36. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
Parsons CG; West DC; Headley PM
Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
[TBL] [Abstract][Full Text] [Related]
37. The effect of intrathecal opioid-receptor agonists on visceral noxious stimulation in rabbits.
Borgbjerg FM; Frigast C; Madsen JB; Mikkelsen LF
Gastroenterology; 1996 Jan; 110(1):139-46. PubMed ID: 8536850
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory effects of centrally injected kappa-opioid receptor agonists on gastric acid secretion in urethane-anesthetized rats.
Ishihara S; Tsuchiya S; Horie S; Murayama T; Watanabe K
Eur J Pharmacol; 2001 Apr; 418(3):187-94. PubMed ID: 11343688
[TBL] [Abstract][Full Text] [Related]
39. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
40. Pharmacology and clinical experience with fedotozine.
Delvaux M
Expert Opin Investig Drugs; 2001 Jan; 10(1):97-110. PubMed ID: 11116283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
